Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Pirtobrutinib |
Trade Name | Jaypirca |
Synonyms | LOXO-305|LOXO 305|LOXO305|RXC005|REDX08608 |
Drug Descriptions |
Jaypirca (pirtobrutinib) selectively inhibits the activation of BTK, which may results in decreased tumor growth (PMID: 32170458, PMID: 33676628). Jaypirca (pirtobrutinib) is FDA approved for use in patients with relapsed or refractory mantle cell lymphoma who had received at least two lines of systemic therapy (FDA.gov). |
DrugClasses | BTK inhibitor 35 |
CAS Registry Number | 2101700-15-4 |
NCIT ID | C158617 |